Kingdom Exim Group CEO, MD awarded honorary doctorates
The Chief Executive Officer (CEO) of Kingdom Exim Group of Companies, James Gnanaraj Rajamani and the Managing Director of the Kingdom Exim Group of Companies, Immanuel Rajamani have been awarded honorary doctorate degrees.
Both of them were awarded honorary doctorates by the University of New England, Connecticut, United States of America.
Immanuel Rajamani received a doctorate of philosophy in executive leadership and business while James Gnanaraj Rajamani was awarded a doctorate of philosophy in Christian Leadership and Business from the University.
They were awarded the honorary doctorate degrees for their immense contributions towards the growth of the business sector in Ghana and beyond.
The doctorates were also presented to them in recognition of their tremendous efforts in growing Kingdom Group of Companies from an organization that started with just two employees to now an entity employing hundreds of people.
They were also honoured for moving Kingdom Exim beyond just a single company to one that now has ten subsidiaries.
The doctorate degrees were presented to them recently at a short but colourful ceremony.
About Kingdom Exim Group
The Kingdom Exim Group has been in existence since 2008, operating mainly in the Bono, Bono East, Ahafo, Greater Accra, Northern, Upper East, and Savannah Region.
As a leading agro-based company, the Group liaises with farmers of tree crops such as Raw cashew Nuts shea-nut, soya bean, maize, among others.
Over the years, the Group has undertaken a number of corporate social responsibility initiatives – drilling boreholes, providing materials for farmers, and providing food during the Covid 19 in the Tema Metropolis, supporting the Tema Regional police with PPE’s, barricades, hand sanitizers, liquid soap, support to Tema East Constituency during the covid 19 pandemic, donation made at the Techiman North District Assembly during the covid 19 pandemic, donation made to the Queen Mother's in areas of the Eastern Region during the Covid 19 pandemic etc.